Harold J. Jennings - Concepedia

Author

Harold J. Jennings

Also Known As

H J Jennings, H Jennings, H. J. JENNINGS, H. J. Jennings, H. Jennings, H.J Jennings, H.J. Jennings, HAROLD J. JENNINGS, Harold J Jennings, Harold J. Jennings

238

Publications

10.2K

Citations

H-Index

136

Concepts

All Affiliations

National Research Council Canada Institute for Biological Sciences Brigham and Women's Hospital Harvard University National Academies of Sciences, Engineering, and Medicine

About

Harold J. Jennings is an author at National Research Council Canada specializing in medicine, glycobiology, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	46	93	5.7K
2	Natural Sciences	30	47	2.6K
3	Engineering	19	27	1.3K
4	Allergy	8	8	408
5	Health Sciences	2	2	130

Harold J. Jennings

152

Publications

9.5K

Citations

H-Index

Page 1

	Year	Citations
Structural determination of the sialic acid polysaccharide antigens of Neisseria meningitidis serogroups B and C with carbon 13 nuclear magnetic resonance. A K Bhattacharjee, Harold J. Jennings, C. P. Kenny, Journal of Biological Chemistry Bioorganic ChemistryImmunologyGlycobiologyEscherichia ColiPolysaccharide	1975	339
Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates. Harold J. Jennings The Journal of Immunology	1981	315
Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. Dennis L. Kasper, Lawrence C. Paoletti, Michael R. Wessels, Journal of Clinical Investigation VaccinationVaccinologyConformationally Dependent EpitopeIii CpsVaccine Development	1996	263
Composition, sequence, and conformation of polymers and oligomers of glucose as revealed by carbon-13 nuclear magnetic resonance Pierre Colson, Harold J. Jennings, Ian C. P. Smith Journal of the American Chemical Society Macromolecular ChemistryEngineeringGlycobiologyAltmetric Attention ScoreOrganic Chemistry	1974	256
Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci. M S Edwards, D. L. Kasper, Harold J. Jennings, The Journal of Immunology	1982	211
Structural elucidation of two capsular polysaccharides from one strain of Bacteroides fragilis using high-resolution NMR spectroscopy Herbert Baumann, A O Tzianabos, Jean‐Robert Brisson, Biochemistry EngineeringGlycobiologyBacteriologyBacteroides FragilisPolysaccharide	1992	195
Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus. Michael R. Wessels, Lawrence C. Paoletti, Dennis L. Kasper, Journal of Clinical Investigation Polysaccharide-protein Conjugate VaccineHumoral ResponseImmunologyGlycobiologyPolysaccharide	1990	191
Determination of the Structure and Conformation of Bacterial Polysaccharides by Carbon 13 Nuclear Magnetic Resonance David R. Bundle, Ian C. P. Smith, Harold J. Jennings Journal of Biological Chemistry	1974	163
Structure of the complex polysaccharide C-substance from Streptococcus pneumoniae type 1 Harold J. Jennings, N. Martin Young Biochemistry GlycosylationBiochemistryGlycobiologyComplex Polysaccharide C-substanceRepeating Unit	1980	149
Induction of meningococcal group B polysaccharide-specific IgG antibodies in mice by using an <i>N</i>-propionylated B polysaccharide-tetanus toxoid conjugate vaccine. Harold J. Jennings, Rahul Roy, Andrzej Gamian The Journal of Immunology	1986	148

Page 1